Breaking News Instant updates and real-time market news.

IMMU

Immunomedics

$15.50

-0.22 (-1.40%)

09:00
01/08/18
01/08
09:00
01/08/18
09:00

Immunomedics trading resumes

  • 08

    Jan

IMMU Immunomedics
$15.50

-0.22 (-1.40%)

11/13/17
WELS
11/13/17
NO CHANGE
Target $14
WELS
Outperform
Immunomedics weakness a buying opportunity, says Wells Fargo
Wells Fargo analyst Jim Birchenough said weakness in Immunomedics is a buying opportunity following review of SABCS abstract data for IIMU132 in TNBC saying he believes the data supports accelerated approval. Birchenough rates Immunomedics an Outperform with a $14 price target.
11/14/17
JEFF
11/14/17
NO CHANGE
Target $16
JEFF
Buy
Jefferies disagrees with yesterday's selloff in Immunomedics
Immunomedics closed down 19% yesterday largely due to interim overall survival data for IMMU-132 and concerns the FDA will require Phase III overall survival data for approval, Jefferies analyst Matthew Andrews tells investors in a research note. The analyst disagrees, and keeps a Buy rating on the shares with a $16 price target. The progression-free survival is the Phase III Special Protocol Assessment's primary endpoint, while the overall survival data may ultimately be confounded by patients' use of other drugs after progression, Andrews tells investors in a research note. Precedent for objective response rate/duration of response exists with FDA breakthrough therapy approvals of 12 solid tumor drugs, some with less robust efficacy than IMMU-132, the analyst adds.
11/14/17
COWN
11/14/17
NO CHANGE
Target $15
COWN
Outperform
Immunomedics drug survival rate disappointing but approval likely, says Cowen
Cowen analyst Phil Nadeau said the overall survival rate for Immunomedics' IMMU-132 showed a decrease, which was disappointing, but the response rate is still well above the current standard of care. As a result, the analyst believes it still appears likely to get accelerated FDA approval. Nadeau reiterated his Outperform rating and $15 price target on Immunomedics shares.
12/06/17
JEFF
12/06/17
NO CHANGE
JEFF
Buy
Immunomedics breast cancer data continue to look 'very solid,' says Jefferies
Jefferies analyst Matthew Andrews says the totality of Immunomedics' Phase II breast cancer data for IMMU-132 "continue to look very solid." Importantly, there was no clinically meaningful decrease in objective response rate per blinded central review, Andrews tells investors in a research note after the company announced updated results. The analyst reiterates a Buy rating and believes the data is sufficient to support FDA accelerated approval.

TODAY'S FREE FLY STORIES

FMC

FMC Corporation

$91.30

-0.22 (-0.24%)

05:41
05/22/18
05/22
05:41
05/22/18
05:41
Hot Stocks
FMC Corporation awarded contract for two fertilizer plants in India »

TechnipFMC, in consortium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.17

0.05 (0.98%)

05:40
05/22/18
05/22
05:40
05/22/18
05:40
Hot Stocks
Sprint partners with Scopeworker on multi-billion dollar 5G depoloyment »

Scopeworker announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSHD

Goosehead Insurance

$16.19

0.12 (0.75%)

05:39
05/22/18
05/22
05:39
05/22/18
05:39
Initiation
Goosehead Insurance initiated  »

Goosehead Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$20.00

0.14 (0.70%)

05:38
05/22/18
05/22
05:38
05/22/18
05:38
Initiation
Smartsheet initiated  »

Smartsheet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

VLRS

Volaris

$5.42

-0.05 (-0.91%)

05:19
05/22/18
05/22
05:19
05/22/18
05:19
Recommendations
Volaris analyst commentary  »

Volaris price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAX

Baxter

$72.08

1.4603 (2.07%)

05:16
05/22/18
05/22
05:16
05/22/18
05:16
Recommendations
Baxter analyst commentary  »

Baxter buybacks should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOCU

DocuSign

$43.06

-1.73 (-3.86%)

05:08
05/22/18
05/22
05:08
05/22/18
05:08
Initiation
DocuSign initiated  »

DocuSign initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

AROC

Archrock

$12.30

0.35 (2.93%)

05:07
05/22/18
05/22
05:07
05/22/18
05:07
Recommendations
Archrock analyst commentary  »

Archrock added to Alpha…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$23.60

-0.065 (-0.27%)

05:05
05/22/18
05/22
05:05
05/22/18
05:05
Recommendations
Pure Storage analyst commentary  »

Pure Storage weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 07

    Jun

  • 12

    Jun

  • 10

    Jul

DOCU

DocuSign

$43.06

-1.73 (-3.86%)

05:02
05/22/18
05/22
05:02
05/22/18
05:02
Initiation
DocuSign initiated  »

DocuSign initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

SSL

Sasol

$37.93

0.05 (0.13%)

05:00
05/22/18
05/22
05:00
05/22/18
05:00
Downgrade
Sasol rating change  »

Sasol downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSHD

Goosehead Insurance

$16.19

0.12 (0.75%)

04:58
05/22/18
05/22
04:58
05/22/18
04:58
Initiation
Goosehead Insurance initiated  »

Goosehead Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALG

Alamo Group

$100.36

1.34 (1.35%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Alamo Group management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

ALNA

Allena Pharmaceuticals

$15.99

-0.01 (-0.06%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Allena Pharmaceuticals management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

CTIC

CTI BioPharma

$4.79

-0.1 (-2.05%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
CTI BioPharma management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

BAYRY

Bayer

$0.00

(0.00%)

, BDX

Becton Dickinson

$228.74

3.73 (1.66%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$228.74

3.73 (1.66%)

BIIB

Biogen

$277.69

-2.66 (-0.95%)

BSX

Boston Scientific

$30.65

0.19 (0.62%)

CELG

Celgene

$74.69

-3.7 (-4.72%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FGEN

FibroGen

$52.55

1.45 (2.84%)

GSK

GlaxoSmithKline

$40.05

0.005 (0.01%)

HRC

Hill-Rom

$90.70

0.12 (0.13%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

RETA

Reata Pharmaceuticals

$31.86

0.28 (0.89%)

OCX

OncoCyte

$2.50

-0.05 (-1.96%)

VVUS

VIVUS

$0.80

0.0079 (1.00%)

NBRV

Nabriva Therapeutics

$4.54

-0.89 (-16.39%)

MYL

Mylan

$39.55

-0.1 (-0.25%)

MASI

Masimo

$97.75

0.64 (0.66%)

TEVA

Teva

$21.09

-0.14 (-0.66%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

JAZZ

Jazz Pharmaceuticals

$166.01

-1.59 (-0.95%)

REGN

Regeneron

$296.58

-5.29 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 07

    Sep

  • 20

    Oct

  • 13

    Nov

  • 20

    Dec

EXTR

Extreme Networks

$9.16

-0.02 (-0.22%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Extreme Networks management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 29

    May

EHTH

eHealth

$20.06

0.26 (1.31%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
eHealth management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 29

    May

SYF

Synchrony

$35.73

0.29 (0.82%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Synchrony management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 30

    May

PES

Pioneer Energy

$6.13

0.275 (4.70%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Pioneer Energy management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

ATO

Atmos Energy

$85.25

0.37 (0.44%)

, AVA

Avista

$52.62

0.07 (0.13%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Credit Suisse to hold meetings at AGA Financial Forum »

Credit Suisse Company…

ATO

Atmos Energy

$85.25

0.37 (0.44%)

AVA

Avista

$52.62

0.07 (0.13%)

BKH

Black Hills

$56.34

0.12 (0.21%)

CMS

CMS Energy

$43.96

-0.16 (-0.36%)

CNP

CenterPoint Energy

$25.21

-0.115 (-0.45%)

D

Dominion

$63.71

0.42 (0.66%)

DTE

DTE Energy

$99.96

0.04 (0.04%)

UK

Union Carbide

$0.00

(0.00%)

ED

Consolidated Edison

$73.82

-0.14 (-0.19%)

NI

NiSource

$24.39

-0.05 (-0.20%)

NJR

New Jersey Resources

$43.15

0.3 (0.70%)

NWE

NorthWestern

$53.48

0.26 (0.49%)

SO

Southern Company

$43.42

0.68 (1.59%)

SR

Spire

$70.08

0.4 (0.57%)

SRE

Sempra Energy

$102.64

0.65 (0.64%)

WEC

WEC Energy

$60.20

-0.3 (-0.50%)

XEL

Xcel Energy

$43.55

-0.15 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 25

    Jun

ALNY

Alnylam

$100.88

-2.12 (-2.06%)

, SNY

Sanofi

$38.78

-0.09 (-0.23%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
World Federation of Hemophilia to hold a conference »

2018 World Congress of…

ALNY

Alnylam

$100.88

-2.12 (-2.06%)

SNY

Sanofi

$38.78

-0.09 (-0.23%)

BMRN

BioMarin

$89.35

0.4 (0.45%)

BAYRY

Bayer

$0.00

(0.00%)

NVO

Novo Nordisk

$48.70

-0.02 (-0.04%)

PFE

Pfizer

$35.79

0.15 (0.42%)

SHPG

Shire

$169.00

-0.62 (-0.37%)

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

QURE

uniQure

$31.44

0.08 (0.26%)

DNA

Bought by RHHBY

$0.00

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 30

    May

  • 05

    Jun

  • 11

    Aug

  • 10

    Sep

  • 12

    Sep

  • 20

    Oct

  • 21

    Dec

  • 28

    Jan

SM

SM Energy

$27.18

0.52 (1.95%)

, APC

Anadarko

$71.69

1.12 (1.59%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
JPMorgan to hold a bus tour »

Denver Energy Bus Tour…

SM

SM Energy

$27.18

0.52 (1.95%)

APC

Anadarko

$71.69

1.12 (1.59%)

QEP

QEP Resources

$13.56

0.395 (3.00%)

WLL

Whiting Petroleum

$53.22

1.21 (2.33%)

HK

Halcon Resources

$5.49

-0.08 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 13

    Jun

  • 19

    Aug

PRA

ProAssurance

$40.10

0.15 (0.38%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
ProAssurance management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

SLD

Sutherland Asset Management

$15.35

0.1 (0.66%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Sutherland Asset Management management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 31

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.